Vincent Serra
Direttore operativo presso NEOVACS
Profilo
Vincent Serra is the founder of Wittycell SAS, which was founded in 2005.
He held the title of Chief Executive & Scientific Officer from 2012 to 2014.
Dr. Serra's current job is as Chief Operations & Scientific Officer at Neovacs SA since 2019.
He is also currently Vice President at BioSupport AG.
Dr. Serra's former job was as Vice President-European Operations at Anosys, Inc. from 1999 to 2005.
He also worked at Abivax SA as VP-Research & Development Viral Vaccines Division.
Dr. Serra obtained a doctorate degree from the University of Grenoble.
Posizioni attive di Vincent Serra
Società | Posizione | Inizio |
---|---|---|
NEOVACS | Direttore operativo | - |
BioSupport AG | Corporate Officer/Principal | - |
Precedenti posizioni note di Vincent Serra
Società | Posizione | Fine |
---|---|---|
Wittycell SAS
Wittycell SAS Pharmaceuticals: MajorHealth Technology Wittycell SAS engages in the research and development, manufacturing, and sale of therapeutic and prophylactic vaccines. It offers novel adjuvant products against infectious diseases and cancer. The company was founded in August 2005 and is headquartered in Reims, France. | Amministratore Delegato | 01/02/2014 |
Anosys, Inc.
Anosys, Inc. Pharmaceuticals: MajorHealth Technology Part of Calyx Ventures, Inc., Anosys, Inc. develops vaccines for infectious diseases and cancer. The company is based in Menlo Park, CA. Anosys was acquired by Chromos Molecular Systems, Inc. from Epimmune, Inc. on March 25, 2005. | Corporate Officer/Principal | 01/02/2005 |
ABIVAX | Corporate Officer/Principal | - |
Formazione di Vincent Serra
University of Grenoble | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
NEOVACS | Health Technology |
ABIVAX | Health Technology |
Aziende private | 3 |
---|---|
Anosys, Inc.
Anosys, Inc. Pharmaceuticals: MajorHealth Technology Part of Calyx Ventures, Inc., Anosys, Inc. develops vaccines for infectious diseases and cancer. The company is based in Menlo Park, CA. Anosys was acquired by Chromos Molecular Systems, Inc. from Epimmune, Inc. on March 25, 2005. | Health Technology |
Wittycell SAS
Wittycell SAS Pharmaceuticals: MajorHealth Technology Wittycell SAS engages in the research and development, manufacturing, and sale of therapeutic and prophylactic vaccines. It offers novel adjuvant products against infectious diseases and cancer. The company was founded in August 2005 and is headquartered in Reims, France. | Health Technology |
BioSupport AG |
- Borsa valori
- Insiders
- Vincent Serra